These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparative analysis of various proposed models of the receptor-bound conformation of H-Tyr-Tic-Phe-OH related delta-opioid antagonists. Wilkes BC; Schiller PW Biopolymers; 1995; 37(6):391-400. PubMed ID: 8589244 [TBL] [Abstract][Full Text] [Related]
3. Development of a model for the delta-opioid receptor pharmacophore: 3. Comparison of the cyclic tetrapeptide, Tyr-c[D-Cys-Phe-D-Pen]OH with other conformationally constrained delta-receptor selective ligands. Lomize AL; Pogozheva ID; Mosberg HI Biopolymers; 1996 Feb; 38(2):221-34. PubMed ID: 8589255 [TBL] [Abstract][Full Text] [Related]
4. A three-dimensional model of the delta-opioid pharmacophore: comparative molecular modeling of peptide and nonpeptide ligands. Shenderovich MD; Liao S; Qian X; Hruby VJ Biopolymers; 2000 Jun; 53(7):565-80. PubMed ID: 10766952 [TBL] [Abstract][Full Text] [Related]
5. Molecular dynamics conformations of deltorphin analogues advocate delta opioid binding site models. Bryant SD; Attila M; Salvadori S; Guerrini R; Lazarus LH Pept Res; 1994; 7(4):175-84. PubMed ID: 7696838 [TBL] [Abstract][Full Text] [Related]
6. Conformational studies of stereoisomeric 14-membered cyclic enkephalin analogues containing 1-naphthylalanine at the fourth position: chirality effect of leucine at the fifth position on biological activity and receptor selectivity. Yamazaki T; Said-Nejad OE; Schiller PW; Goodman M Biopolymers; 1991 Jun; 31(7):877-98. PubMed ID: 1655089 [TBL] [Abstract][Full Text] [Related]
7. The use of topographical constraints in receptor mapping: investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH2 (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and delta-opioid receptors. Boteju LW; Nikiforovich GV; Haskell-Luevano C; Fang SN; Zalewska T; Stropova D; Yamamura HI; Hruby VJ J Med Chem; 1996 Sep; 39(20):4120-4. PubMed ID: 8831778 [TBL] [Abstract][Full Text] [Related]
8. Investigation of the structural parameters involved in the delta-opioid selectivity of several families of opioid peptides. Guis C; Bruetschy L; Meudal H; Roques BP; Gacel GA Int J Pept Protein Res; 1993 Jun; 41(6):576-86. PubMed ID: 8394291 [TBL] [Abstract][Full Text] [Related]
9. Examination of the conformational meaning of "delta-address" in the dermenkephalin sequence. Nikiforovich GV; Hruby VJ Biochem Biophys Res Commun; 1990 Dec; 173(2):521-7. PubMed ID: 1979733 [TBL] [Abstract][Full Text] [Related]
10. Folding trends in a flexible peptide: two-dimensional NMR study of deltorphin-I, a delta selective opioid heptapeptide. Duchesne D; Naim M; Nicolas P; Baron D Biochem Biophys Res Commun; 1993 Sep; 195(2):630-6. PubMed ID: 8373402 [TBL] [Abstract][Full Text] [Related]
11. Differential regulation of mu and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastoma cells. Zadina JE; Harrison LM; Ge LJ; Kastin AJ; Chang SL J Pharmacol Exp Ther; 1994 Sep; 270(3):1086-96. PubMed ID: 7932156 [TBL] [Abstract][Full Text] [Related]
12. Conformational features responsible for the binding of cyclic analogues of enkephalin to opioid receptors. III. Probable binding conformations of mu-agonists with phenylalanine in position 3. Shenderovich MD; Nikiforovich GV; Golbraikh AA Int J Pept Protein Res; 1991 Apr; 37(4):241-51. PubMed ID: 1654306 [TBL] [Abstract][Full Text] [Related]
13. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens. Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831 [TBL] [Abstract][Full Text] [Related]
15. The delta-selective opioid peptide dermenkephalin and the mu-selective hybrid peptide dermenkephalin-[1-4]-dermophin-[5-7] display strikingly different conformations despite identical tetrapeptide N-termini. A quantitative 2-D NMR and molecular modeling analysis. Riand J; Baron D; Nicolas P; Benajiba A; Teng Y; Naim M J Biomol Struct Dyn; 1999 Dec; 17(3):445-60. PubMed ID: 10636080 [TBL] [Abstract][Full Text] [Related]
16. Identification of mechanisms and sites of actions of mu and delta opioid receptor activation in the canine intestine. Fox-Threlkeld JE; Daniel EE; Christinck F; Hruby VJ; Cipris S; Woskowska Z J Pharmacol Exp Ther; 1994 Feb; 268(2):689-700. PubMed ID: 8113980 [TBL] [Abstract][Full Text] [Related]
17. Conformational determinants of high affinity delta receptor binding of opioid peptides. Keys C; Payne P; Amsterdam P; Toll L; Loew G Mol Pharmacol; 1988 May; 33(5):528-36. PubMed ID: 2835652 [TBL] [Abstract][Full Text] [Related]
18. Quantitative two-dimensional NMR study of dermenkephalin, a highly potent and selective delta-opioid peptide. Naim M; Charpentier S; Nicolas P; Baron D Biopolymers; 1993 Dec; 33(12):1889-900. PubMed ID: 8268413 [TBL] [Abstract][Full Text] [Related]
19. New insights on mu/delta selectivity of opioid peptides: conformational analysis of deltorphin analogues. Tancredi T; Temussi PA; Picone D; Amodeo P; Tomatis R; Salvadori S; Marastoni M; Santagada V; Balboni G Biopolymers; 1991 May; 31(6):751-60. PubMed ID: 1932571 [TBL] [Abstract][Full Text] [Related]
20. [Approach to studying the structure-activity relationship of native peptides. I. Structural organization of the opioid peptide Tyr-Glu-Gly-Phe-Met-Arg-Gly-Leu and its artificial analogs]. Popov EM; Akhmedov NA; Makhmudova TA Bioorg Khim; 1992 Dec; 18(12):1454-63. PubMed ID: 1300997 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]